China Universal Asset Management Company’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-325
Closed -$2.91K 465
2023
Q3
$2.91K Buy
325
+160
+97% +$1.43K ﹤0.01% 417
2023
Q2
$1.43K Sell
165
-6
-4% -$52 ﹤0.01% 442
2023
Q1
$1.8K Buy
171
+44
+35% +$464 ﹤0.01% 434
2022
Q4
$4.32K Buy
127
+10
+9% +$340 ﹤0.01% 312
2022
Q3
$6K Buy
+117
New +$6K ﹤0.01% 258